Biota Structural Biology Laboratory, St. Vincent's Institute of Medical Research, Victoria 3065, Australia.
Protein Sci. 2011 Jun;20(6):1060-8. doi: 10.1002/pro.631. Epub 2011 Apr 27.
Infection by Leishmania and Trypanosoma causes severe disease and can be fatal. The reduced effectiveness of current treatments is largely due to drug resistance, hence the urgent need to develop new drugs, preferably against novel targets. We have recently identified a mitochondrial membrane-anchored protein, designated MIX, which occurs exclusively in these parasites and is essential for virulence. We have determined the crystal structure of Leishmania major MIX to a resolution of 2.4 Å. MIX forms an all α-helical fold comprising seven α-helices that fold into a single domain. The distribution of helices is similar to a number of scaffold proteins, namely HEAT repeats, 14-3-3, and tetratricopeptide repeat proteins, suggesting that MIX mediates protein-protein interactions. Accordingly, using copurification and mass spectroscopy we were able to identify several proteins that may interact with MIX in vivo. Being parasite specific, MIX is a promising new drug target and, thus, the structure and potential interacting partners provide a basis for structure-guided drug discovery.
利什曼原虫和锥虫感染可导致严重疾病,并可能致命。目前治疗方法的效果降低在很大程度上是由于药物耐药性,因此迫切需要开发新的药物,最好针对新的靶点。我们最近发现了一种定位于线粒体膜的蛋白,称为 MIX,它仅存在于这些寄生虫中,对毒力至关重要。我们已经确定了 2.4Å分辨率的利什曼原虫 MIX 的晶体结构。MIX 形成一个全α-螺旋折叠,由七个α-螺旋组成,折叠成一个单一的结构域。螺旋的分布类似于许多支架蛋白,即 HEAT 重复序列、14-3-3 和四肽重复蛋白,表明 MIX 介导蛋白质-蛋白质相互作用。因此,我们使用共纯化和质谱技术能够鉴定出几种可能在体内与 MIX 相互作用的蛋白质。由于寄生虫特异性,MIX 是一个很有前途的新药物靶点,因此结构和潜在的相互作用伙伴为基于结构的药物发现提供了基础。